Skip Navigation
Return to All Schools

Guerrieri Family Professorship in Ophthalmology in the Center for Genetic Engineering & Molecular Ophthalmology at the Wilmer Institute

School of Medicine

Established in 1998 by the Guerrieri Family Foundation

GuerrieriAlanThe GUERRIERI FAMILY FOUNDATION, headed by M. ALAN GUERRIERI, has generously supported Hopkins in many ways, including funding for the Guerrieri Family Reception Area in the Johns Hopkins Outpatient Center. In 1994, the foundation provided support to create the Alan Guerrieri Family Research Endowment in Retinal Diseases at the Wilmer Eye Institute, the radiology viewing room in the Harry and Jeanette Weinberg Building, and the Alan Guerrieri Family Education Fund in the Department of Medicine.

Past president of his family’s business, Showell Farms, Alan Guerrieri guided the poultry processing business to great success; ultimately it was sold to Perdue Incorporated. Alan Guerrieri is a member of the Wilmer Advisory Council, as was his late wife, PATTY GUERRIERI, and Mr. Guerrieri is a past member of the National Council for Johns Hopkins Medicine.

Held by Donald J. Zack

ZackDonaldDONALD J. ZACK, MD, PhD, is the inaugural Guerrieri Professor of Genetic Engineering and Molecular Ophthalmology and co-director of the Center for Stem Cells and Ocular Regenerative Medicine (STORM) at the Wilmer Eye Institute. He is also a professor in the departments of Molecular Biology and Genetics, Neuroscience, and the Institute of Genetic Medicine. His lab studies the control of gene expression in retinal ganglion cells, the cells whose death in glaucoma leads to visual loss and potentially blindness. He also studies the mechanisms by which ganglion cells die in glaucoma and is developing novel methods to slow down, and hopefully prevent, ganglion cell death in glaucoma. Dr. Zack and his colleagues are beginning studies to promote the differentiation of stem cells into retinal ganglion cells in the hope that someday that might offer the possibility of restoring vision to glaucoma patients who have already lost significant vision due to ganglion cell death.

Dr. Zack received his MD degree and PhD in molecular immunology from the Albert Einstein College of Medicine. After a year of internship, he completed his residency in ophthalmology at the Massachusetts Eye and Ear Infirmary at Harvard University. He then completed fellowship training in glaucoma and molecular biology at the Johns Hopkins University School of Medicine and joined the faculty in 1991. Dr. Zack has published over 160 peer-reviewed journal articles and has won a number of awards, including the Alcon Research Award.